Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancerDan Yang, Anhui Shi, Jianing Cui et al.|Thoracic Cancer|2020Cited by 16
Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma MarkersXin Sui, Weihu Wang, Leilei Jiang et al.|Frontiers in Oncology|2021Cited by 13
Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literatureDan Yang, Mingzhi Zhang, Xiaorui Fu et al.|Oncology Letters|2015Cited by 8